Blog

Richard Lee: Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium

Collage Photo of Drs. Collin Weekes, Regina Brown, Luckson Mathieu and Erica Stringer-Reasor

Jun 21, 2024, 06:24

Richard Lee: Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium

Erica Stringer-Reasor, Vice Chairperson at The University of Alabama at Birmingham, shared a post by Richard Lee, Genitourinary medical oncologist at Mass General in Boston, on X:

“Thank you Dr. Colin Weekes and Mass General Cancer Center for inviting me to the Cancer Equity Colloquium to discuss the important topic of clinical trial diversification.”

The post by Richard Lee:

“Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium with Drs. Weekes, Brown, Mathieu, and Stringer-Reasor.”

Source: Erica Stringer-Reasor/X and Richard Lee/X

Brown cancer Cancer Equity Colloquium clinical trial diversification Colin Weekes Erica Stringer-Reasor Mass General Cancer Center Mathieu OncoDaily Oncology Richard Lee

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers